nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—UGT2B7—Mycophenolic acid—psoriasis	0.0917	0.125	CbGbCtD
Zidovudine—UGT2B7—Mycophenolate mofetil—psoriasis	0.0512	0.07	CbGbCtD
Zidovudine—CYP2A6—Methoxsalen—psoriasis	0.0458	0.0626	CbGbCtD
Zidovudine—ALB—Acitretin—psoriasis	0.0358	0.049	CbGbCtD
Zidovudine—CYP2C8—Tazarotene—psoriasis	0.035	0.0479	CbGbCtD
Zidovudine—ABCG2—Mycophenolate mofetil—psoriasis	0.0243	0.0333	CbGbCtD
Zidovudine—CYP2A6—Prednisolone—psoriasis	0.0223	0.0304	CbGbCtD
Zidovudine—ABCG2—Hydrocortisone—psoriasis	0.0195	0.0267	CbGbCtD
Zidovudine—SLC22A11—Methotrexate—psoriasis	0.0195	0.0267	CbGbCtD
Zidovudine—SLC22A7—Methotrexate—psoriasis	0.0186	0.0254	CbGbCtD
Zidovudine—ABCG2—Cyclosporine—psoriasis	0.0185	0.0252	CbGbCtD
Zidovudine—ABCC4—Methotrexate—psoriasis	0.0182	0.0248	CbGbCtD
Zidovudine—ALB—Mycophenolate mofetil—psoriasis	0.0168	0.0229	CbGbCtD
Zidovudine—CYP2C8—Cholecalciferol—psoriasis	0.015	0.0204	CbGbCtD
Zidovudine—SLC22A6—Cyclosporine—psoriasis	0.0149	0.0204	CbGbCtD
Zidovudine—ALB—Prednisone—psoriasis	0.0134	0.0183	CbGbCtD
Zidovudine—CYP2A6—Dexamethasone—psoriasis	0.0131	0.0179	CbGbCtD
Zidovudine—CYP2C8—Mycophenolate mofetil—psoriasis	0.013	0.0177	CbGbCtD
Zidovudine—CYP2C19—Cholecalciferol—psoriasis	0.0125	0.0171	CbGbCtD
Zidovudine—ABCG2—Dexamethasone—psoriasis	0.0122	0.0166	CbGbCtD
Zidovudine—CYP3A4—Calcitriol—psoriasis	0.0118	0.0161	CbGbCtD
Zidovudine—SLC22A8—Methotrexate—psoriasis	0.0113	0.0155	CbGbCtD
Zidovudine—CYP2C9—Cholecalciferol—psoriasis	0.0104	0.0143	CbGbCtD
Zidovudine—CYP2C8—Hydrocortisone—psoriasis	0.0104	0.0142	CbGbCtD
Zidovudine—CYP2C8—Cyclosporine—psoriasis	0.00983	0.0134	CbGbCtD
Zidovudine—ABCG2—Methotrexate—psoriasis	0.00976	0.0133	CbGbCtD
Zidovudine—CYP3A4—Methoxsalen—psoriasis	0.00916	0.0125	CbGbCtD
Zidovudine—ABCB1—Mycophenolate mofetil—psoriasis	0.00878	0.012	CbGbCtD
Zidovudine—CYP2C19—Prednisone—psoriasis	0.0087	0.0119	CbGbCtD
Zidovudine—CYP2C19—Cyclosporine—psoriasis	0.00825	0.0113	CbGbCtD
Zidovudine—SLC22A6—Methotrexate—psoriasis	0.0079	0.0108	CbGbCtD
Zidovudine—ABCB1—Betamethasone—psoriasis	0.00753	0.0103	CbGbCtD
Zidovudine—ABCB1—Prednisolone—psoriasis	0.00743	0.0102	CbGbCtD
Zidovudine—ABCB1—Hydrocortisone—psoriasis	0.00705	0.00963	CbGbCtD
Zidovudine—ABCB1—Prednisone—psoriasis	0.00702	0.00959	CbGbCtD
Zidovudine—CYP2C9—Cyclosporine—psoriasis	0.00686	0.00937	CbGbCtD
Zidovudine—ALB—Methotrexate—psoriasis	0.00673	0.0092	CbGbCtD
Zidovudine—ABCB1—Cyclosporine—psoriasis	0.00665	0.00909	CbGbCtD
Zidovudine—CYP2C8—Dexamethasone—psoriasis	0.00647	0.00885	CbGbCtD
Zidovudine—CYP3A4—Cholecalciferol—psoriasis	0.00607	0.00829	CbGbCtD
Zidovudine—CYP2C19—Dexamethasone—psoriasis	0.00543	0.00742	CbGbCtD
Zidovudine—TERT—Mycophenolic acid—Mycophenolate mofetil—psoriasis	0.00542	1	CbGdCrCtD
Zidovudine—CYP3A4—Mycophenolate mofetil—psoriasis	0.00526	0.00719	CbGbCtD
Zidovudine—CYP3A4—Triamcinolone—psoriasis	0.00526	0.00719	CbGbCtD
Zidovudine—CYP2C9—Dexamethasone—psoriasis	0.00451	0.00617	CbGbCtD
Zidovudine—CYP3A4—Betamethasone—psoriasis	0.00451	0.00617	CbGbCtD
Zidovudine—CYP3A4—Prednisolone—psoriasis	0.00445	0.00608	CbGbCtD
Zidovudine—ABCB1—Dexamethasone—psoriasis	0.00438	0.00599	CbGbCtD
Zidovudine—CYP3A4—Hydrocortisone—psoriasis	0.00422	0.00577	CbGbCtD
Zidovudine—CYP3A4—Prednisone—psoriasis	0.0042	0.00575	CbGbCtD
Zidovudine—CYP3A4—Cyclosporine—psoriasis	0.00399	0.00545	CbGbCtD
Zidovudine—ABCB1—Methotrexate—psoriasis	0.00352	0.00481	CbGbCtD
Zidovudine—CYP3A4—Dexamethasone—psoriasis	0.00263	0.00359	CbGbCtD
Zidovudine—TK1—Metabolism—CYP2S1—psoriasis	0.000188	0.00466	CbGpPWpGaD
Zidovudine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.000187	0.00465	CbGpPWpGaD
Zidovudine—UGT2B7—NRF2 pathway—TGFA—psoriasis	0.000179	0.00446	CbGpPWpGaD
Zidovudine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000178	0.00442	CbGpPWpGaD
Zidovudine—SLC29A2—Transmembrane transport of small molecules—CP—psoriasis	0.000178	0.00442	CbGpPWpGaD
Zidovudine—TERT—TGF-beta Signaling Pathway—JUN—psoriasis	0.000177	0.00439	CbGpPWpGaD
Zidovudine—TERT—Validated targets of C-MYC transcriptional activation—TP53—psoriasis	0.000176	0.00437	CbGpPWpGaD
Zidovudine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000172	0.00427	CbGpPWpGaD
Zidovudine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	0.00017	0.00422	CbGpPWpGaD
Zidovudine—SLC29A2—Transmembrane transport of small molecules—CARM1—psoriasis	0.00017	0.00422	CbGpPWpGaD
Zidovudine—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000169	0.00421	CbGpPWpGaD
Zidovudine—ABCC4—NRF2 pathway—TGFA—psoriasis	0.000168	0.00419	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—HCAR2—psoriasis	0.000157	0.0039	CbGpPWpGaD
Zidovudine—ABCC5—Fluoropyrimidine Activity—TP53—psoriasis	0.000156	0.00387	CbGpPWpGaD
Zidovudine—SLC22A11—SLC-mediated transmembrane transport—CP—psoriasis	0.000152	0.00378	CbGpPWpGaD
Zidovudine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000139	0.00346	CbGpPWpGaD
Zidovudine—SLC22A7—SLC-mediated transmembrane transport—CP—psoriasis	0.000138	0.00343	CbGpPWpGaD
Zidovudine—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000138	0.00342	CbGpPWpGaD
Zidovudine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000137	0.00341	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TAGAP—psoriasis	0.000136	0.00338	CbGpPWpGaD
Zidovudine—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000136	0.00338	CbGpPWpGaD
Zidovudine—SLC22A7—Fluoropyrimidine Activity—TP53—psoriasis	0.000134	0.00333	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000132	0.00329	CbGpPWpGaD
Zidovudine—ALB—Lipoprotein metabolism—APOE—psoriasis	0.000129	0.00321	CbGpPWpGaD
Zidovudine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000128	0.00318	CbGpPWpGaD
Zidovudine—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000123	0.00306	CbGpPWpGaD
Zidovudine—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000121	0.00301	CbGpPWpGaD
Zidovudine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00012	0.00297	CbGpPWpGaD
Zidovudine—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000119	0.00296	CbGpPWpGaD
Zidovudine—TERT—TGF-beta Signaling Pathway—TP53—psoriasis	0.000117	0.0029	CbGpPWpGaD
Zidovudine—SLC22A8—SLC-mediated transmembrane transport—CP—psoriasis	0.000116	0.00289	CbGpPWpGaD
Zidovudine—CYP2A6—NRF2 pathway—TGFA—psoriasis	0.000112	0.00279	CbGpPWpGaD
Zidovudine—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000112	0.00279	CbGpPWpGaD
Zidovudine—ABCG2—HIF-1-alpha transcription factor network—LEP—psoriasis	0.000111	0.00277	CbGpPWpGaD
Zidovudine—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000111	0.00275	CbGpPWpGaD
Zidovudine—ABCC4—Fluoropyrimidine Activity—TP53—psoriasis	0.000108	0.00268	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—SERPINB8—psoriasis	0.000105	0.00262	CbGpPWpGaD
Zidovudine—ABCG2—HIF-1-alpha transcription factor network—NOS2—psoriasis	0.000104	0.00258	CbGpPWpGaD
Zidovudine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—psoriasis	0.000102	0.00254	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—PCNA—psoriasis	0.000102	0.00254	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000102	0.00254	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—IL13—psoriasis	0.000101	0.00252	CbGpPWpGaD
Zidovudine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	0.000101	0.0025	CbGpPWpGaD
Zidovudine—SLC22A6—SLC-mediated transmembrane transport—CP—psoriasis	9.69e-05	0.00241	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—IL17A—psoriasis	9.33e-05	0.00232	CbGpPWpGaD
Zidovudine—TK1—Metabolism—CARM1—psoriasis	9.16e-05	0.00228	CbGpPWpGaD
Zidovudine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.92e-05	0.00222	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—CAT—psoriasis	8.85e-05	0.0022	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—NDUFA5—psoriasis	8.78e-05	0.00218	CbGpPWpGaD
Zidovudine—Dizziness—Mycophenolic acid—psoriasis	8.74e-05	0.000393	CcSEcCtD
Zidovudine—Epistaxis—Methotrexate—psoriasis	8.74e-05	0.000393	CcSEcCtD
Zidovudine—Paraesthesia—Prednisolone—psoriasis	8.74e-05	0.000393	CcSEcCtD
Zidovudine—Mental disorder—Prednisone—psoriasis	8.72e-05	0.000392	CcSEcCtD
Zidovudine—ABCB1—Allograft Rejection—IL12B—psoriasis	8.67e-05	0.00216	CbGpPWpGaD
Zidovudine—Erythema—Prednisone—psoriasis	8.67e-05	0.000389	CcSEcCtD
Zidovudine—Malnutrition—Prednisone—psoriasis	8.67e-05	0.000389	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	8.66e-05	0.000389	CcSEcCtD
Zidovudine—Hyperhidrosis—Triamcinolone—psoriasis	8.65e-05	0.000389	CcSEcCtD
Zidovudine—Agranulocytosis—Methotrexate—psoriasis	8.65e-05	0.000389	CcSEcCtD
Zidovudine—ALB—Vitamin B12 Metabolism—CRP—psoriasis	8.64e-05	0.00215	CbGpPWpGaD
Zidovudine—Convulsion—Dexamethasone—psoriasis	8.62e-05	0.000387	CcSEcCtD
Zidovudine—Convulsion—Betamethasone—psoriasis	8.62e-05	0.000387	CcSEcCtD
Zidovudine—Feeling abnormal—Mycophenolate mofetil—psoriasis	8.6e-05	0.000386	CcSEcCtD
Zidovudine—Insomnia—Hydrocortisone—psoriasis	8.6e-05	0.000386	CcSEcCtD
Zidovudine—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	8.59e-05	0.00213	CbGpPWpGaD
Zidovudine—Paraesthesia—Hydrocortisone—psoriasis	8.54e-05	0.000383	CcSEcCtD
Zidovudine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	8.53e-05	0.000383	CcSEcCtD
Zidovudine—Urticaria—Cyclosporine—psoriasis	8.5e-05	0.000382	CcSEcCtD
Zidovudine—Myalgia—Dexamethasone—psoriasis	8.47e-05	0.000381	CcSEcCtD
Zidovudine—Myalgia—Betamethasone—psoriasis	8.47e-05	0.000381	CcSEcCtD
Zidovudine—ABCB1—Allograft Rejection—HLA-E—psoriasis	8.47e-05	0.0021	CbGpPWpGaD
Zidovudine—Body temperature increased—Cyclosporine—psoriasis	8.46e-05	0.00038	CcSEcCtD
Zidovudine—Abdominal pain—Cyclosporine—psoriasis	8.46e-05	0.00038	CcSEcCtD
Zidovudine—ALB—Vitamin B12 Metabolism—APOE—psoriasis	8.45e-05	0.0021	CbGpPWpGaD
Zidovudine—Anxiety—Dexamethasone—psoriasis	8.44e-05	0.000379	CcSEcCtD
Zidovudine—Anxiety—Betamethasone—psoriasis	8.44e-05	0.000379	CcSEcCtD
Zidovudine—Vomiting—Mycophenolic acid—psoriasis	8.41e-05	0.000378	CcSEcCtD
Zidovudine—Discomfort—Dexamethasone—psoriasis	8.37e-05	0.000376	CcSEcCtD
Zidovudine—Discomfort—Betamethasone—psoriasis	8.37e-05	0.000376	CcSEcCtD
Zidovudine—Dyspepsia—Hydrocortisone—psoriasis	8.37e-05	0.000376	CcSEcCtD
Zidovudine—Rash—Mycophenolic acid—psoriasis	8.34e-05	0.000375	CcSEcCtD
Zidovudine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.33e-05	0.00207	CbGpPWpGaD
Zidovudine—Dermatitis—Mycophenolic acid—psoriasis	8.33e-05	0.000374	CcSEcCtD
Zidovudine—Pain—Prednisolone—psoriasis	8.32e-05	0.000374	CcSEcCtD
Zidovudine—Hepatitis—Methotrexate—psoriasis	8.32e-05	0.000374	CcSEcCtD
Zidovudine—Urticaria—Mycophenolate mofetil—psoriasis	8.29e-05	0.000372	CcSEcCtD
Zidovudine—Headache—Mycophenolic acid—psoriasis	8.28e-05	0.000372	CcSEcCtD
Zidovudine—Decreased appetite—Hydrocortisone—psoriasis	8.26e-05	0.000371	CcSEcCtD
Zidovudine—Pharyngitis—Methotrexate—psoriasis	8.26e-05	0.000371	CcSEcCtD
Zidovudine—Abdominal pain—Mycophenolate mofetil—psoriasis	8.25e-05	0.000371	CcSEcCtD
Zidovudine—Body temperature increased—Mycophenolate mofetil—psoriasis	8.25e-05	0.000371	CcSEcCtD
Zidovudine—Urinary tract disorder—Methotrexate—psoriasis	8.22e-05	0.000369	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Hydrocortisone—psoriasis	8.21e-05	0.000369	CcSEcCtD
Zidovudine—Fatigue—Hydrocortisone—psoriasis	8.2e-05	0.000368	CcSEcCtD
Zidovudine—ABCC5—Transmembrane transport of small molecules—CP—psoriasis	8.16e-05	0.00203	CbGpPWpGaD
Zidovudine—Urethral disorder—Methotrexate—psoriasis	8.16e-05	0.000366	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Triamcinolone—psoriasis	8.15e-05	0.000366	CcSEcCtD
Zidovudine—TERT—Signaling Pathways—CCL20—psoriasis	8.14e-05	0.00203	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—IL4—psoriasis	8.13e-05	0.00202	CbGpPWpGaD
Zidovudine—Pain—Hydrocortisone—psoriasis	8.13e-05	0.000365	CcSEcCtD
Zidovudine—Anaphylactic shock—Dexamethasone—psoriasis	8.12e-05	0.000365	CcSEcCtD
Zidovudine—Anaphylactic shock—Betamethasone—psoriasis	8.12e-05	0.000365	CcSEcCtD
Zidovudine—Oedema—Dexamethasone—psoriasis	8.12e-05	0.000365	CcSEcCtD
Zidovudine—Oedema—Betamethasone—psoriasis	8.12e-05	0.000365	CcSEcCtD
Zidovudine—Insomnia—Triamcinolone—psoriasis	8.1e-05	0.000364	CcSEcCtD
Zidovudine—SLC22A2—SLC-mediated transmembrane transport—CP—psoriasis	8.08e-05	0.00201	CbGpPWpGaD
Zidovudine—Ill-defined disorder—Prednisone—psoriasis	8.04e-05	0.000361	CcSEcCtD
Zidovudine—Paraesthesia—Triamcinolone—psoriasis	8.04e-05	0.000361	CcSEcCtD
Zidovudine—Feeling abnormal—Prednisolone—psoriasis	8.02e-05	0.00036	CcSEcCtD
Zidovudine—Anaemia—Prednisone—psoriasis	8.01e-05	0.00036	CcSEcCtD
Zidovudine—Shock—Dexamethasone—psoriasis	7.99e-05	0.000359	CcSEcCtD
Zidovudine—Shock—Betamethasone—psoriasis	7.99e-05	0.000359	CcSEcCtD
Zidovudine—Dyspnoea—Triamcinolone—psoriasis	7.98e-05	0.000359	CcSEcCtD
Zidovudine—Nervous system disorder—Dexamethasone—psoriasis	7.96e-05	0.000358	CcSEcCtD
Zidovudine—Nervous system disorder—Betamethasone—psoriasis	7.96e-05	0.000358	CcSEcCtD
Zidovudine—Thrombocytopenia—Betamethasone—psoriasis	7.95e-05	0.000357	CcSEcCtD
Zidovudine—Thrombocytopenia—Dexamethasone—psoriasis	7.95e-05	0.000357	CcSEcCtD
Zidovudine—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	7.94e-05	0.00197	CbGpPWpGaD
Zidovudine—Angioedema—Prednisone—psoriasis	7.92e-05	0.000356	CcSEcCtD
Zidovudine—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	7.91e-05	0.00197	CbGpPWpGaD
Zidovudine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.88e-05	0.00196	CbGpPWpGaD
Zidovudine—Dyspepsia—Triamcinolone—psoriasis	7.88e-05	0.000354	CcSEcCtD
Zidovudine—Erythema multiforme—Methotrexate—psoriasis	7.87e-05	0.000353	CcSEcCtD
Zidovudine—Nausea—Mycophenolic acid—psoriasis	7.85e-05	0.000353	CcSEcCtD
Zidovudine—Hyperhidrosis—Betamethasone—psoriasis	7.85e-05	0.000353	CcSEcCtD
Zidovudine—Hyperhidrosis—Dexamethasone—psoriasis	7.85e-05	0.000353	CcSEcCtD
Zidovudine—Feeling abnormal—Hydrocortisone—psoriasis	7.83e-05	0.000352	CcSEcCtD
Zidovudine—Malaise—Prednisone—psoriasis	7.81e-05	0.000351	CcSEcCtD
Zidovudine—Vertigo—Prednisone—psoriasis	7.79e-05	0.00035	CcSEcCtD
Zidovudine—ABCC5—Transmembrane transport of small molecules—CARM1—psoriasis	7.78e-05	0.00194	CbGpPWpGaD
Zidovudine—Gastrointestinal pain—Hydrocortisone—psoriasis	7.77e-05	0.000349	CcSEcCtD
Zidovudine—Syncope—Prednisone—psoriasis	7.77e-05	0.000349	CcSEcCtD
Zidovudine—Anorexia—Betamethasone—psoriasis	7.74e-05	0.000348	CcSEcCtD
Zidovudine—Anorexia—Dexamethasone—psoriasis	7.74e-05	0.000348	CcSEcCtD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—CP—psoriasis	7.74e-05	0.00192	CbGpPWpGaD
Zidovudine—Urticaria—Prednisolone—psoriasis	7.73e-05	0.000347	CcSEcCtD
Zidovudine—Cardiac disorder—Methotrexate—psoriasis	7.72e-05	0.000347	CcSEcCtD
Zidovudine—Fatigue—Triamcinolone—psoriasis	7.72e-05	0.000347	CcSEcCtD
Zidovudine—Asthenia—Cyclosporine—psoriasis	7.67e-05	0.000345	CcSEcCtD
Zidovudine—Pain—Triamcinolone—psoriasis	7.65e-05	0.000344	CcSEcCtD
Zidovudine—Loss of consciousness—Prednisone—psoriasis	7.62e-05	0.000342	CcSEcCtD
Zidovudine—Pruritus—Cyclosporine—psoriasis	7.57e-05	0.00034	CcSEcCtD
Zidovudine—Urticaria—Hydrocortisone—psoriasis	7.55e-05	0.000339	CcSEcCtD
Zidovudine—Body temperature increased—Hydrocortisone—psoriasis	7.51e-05	0.000338	CcSEcCtD
Zidovudine—Abdominal pain—Hydrocortisone—psoriasis	7.51e-05	0.000338	CcSEcCtD
Zidovudine—Convulsion—Prednisone—psoriasis	7.51e-05	0.000337	CcSEcCtD
Zidovudine—Mediastinal disorder—Methotrexate—psoriasis	7.5e-05	0.000337	CcSEcCtD
Zidovudine—Asthenia—Mycophenolate mofetil—psoriasis	7.49e-05	0.000336	CcSEcCtD
Zidovudine—ABCC5—Metabolism—CYP2S1—psoriasis	7.47e-05	0.00186	CbGpPWpGaD
Zidovudine—Chills—Methotrexate—psoriasis	7.46e-05	0.000335	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Dexamethasone—psoriasis	7.4e-05	0.000332	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Betamethasone—psoriasis	7.4e-05	0.000332	CcSEcCtD
Zidovudine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	7.39e-05	0.00184	CbGpPWpGaD
Zidovudine—Pruritus—Mycophenolate mofetil—psoriasis	7.38e-05	0.000332	CcSEcCtD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—CARM1—psoriasis	7.38e-05	0.00183	CbGpPWpGaD
Zidovudine—Arthralgia—Prednisone—psoriasis	7.38e-05	0.000331	CcSEcCtD
Zidovudine—Myalgia—Prednisone—psoriasis	7.38e-05	0.000331	CcSEcCtD
Zidovudine—Feeling abnormal—Triamcinolone—psoriasis	7.38e-05	0.000331	CcSEcCtD
Zidovudine—Anxiety—Prednisone—psoriasis	7.35e-05	0.00033	CcSEcCtD
Zidovudine—Insomnia—Dexamethasone—psoriasis	7.35e-05	0.00033	CcSEcCtD
Zidovudine—Insomnia—Betamethasone—psoriasis	7.35e-05	0.00033	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	7.33e-05	0.000329	CcSEcCtD
Zidovudine—Diarrhoea—Cyclosporine—psoriasis	7.32e-05	0.000329	CcSEcCtD
Zidovudine—Paraesthesia—Betamethasone—psoriasis	7.29e-05	0.000328	CcSEcCtD
Zidovudine—Paraesthesia—Dexamethasone—psoriasis	7.29e-05	0.000328	CcSEcCtD
Zidovudine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	7.29e-05	0.00181	CbGpPWpGaD
Zidovudine—Discomfort—Prednisone—psoriasis	7.29e-05	0.000327	CcSEcCtD
Zidovudine—Mental disorder—Methotrexate—psoriasis	7.29e-05	0.000327	CcSEcCtD
Zidovudine—Malnutrition—Methotrexate—psoriasis	7.24e-05	0.000325	CcSEcCtD
Zidovudine—Erythema—Methotrexate—psoriasis	7.24e-05	0.000325	CcSEcCtD
Zidovudine—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	7.19e-05	0.00179	CbGpPWpGaD
Zidovudine—Dyspepsia—Betamethasone—psoriasis	7.15e-05	0.000321	CcSEcCtD
Zidovudine—Dyspepsia—Dexamethasone—psoriasis	7.15e-05	0.000321	CcSEcCtD
Zidovudine—Diarrhoea—Mycophenolate mofetil—psoriasis	7.14e-05	0.000321	CcSEcCtD
Zidovudine—Urticaria—Triamcinolone—psoriasis	7.11e-05	0.000319	CcSEcCtD
Zidovudine—Dysgeusia—Methotrexate—psoriasis	7.09e-05	0.000319	CcSEcCtD
Zidovudine—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	7.09e-05	0.00176	CbGpPWpGaD
Zidovudine—Body temperature increased—Triamcinolone—psoriasis	7.08e-05	0.000318	CcSEcCtD
Zidovudine—Dizziness—Cyclosporine—psoriasis	7.07e-05	0.000318	CcSEcCtD
Zidovudine—Anaphylactic shock—Prednisone—psoriasis	7.07e-05	0.000318	CcSEcCtD
Zidovudine—Oedema—Prednisone—psoriasis	7.07e-05	0.000318	CcSEcCtD
Zidovudine—Decreased appetite—Dexamethasone—psoriasis	7.06e-05	0.000317	CcSEcCtD
Zidovudine—Decreased appetite—Betamethasone—psoriasis	7.06e-05	0.000317	CcSEcCtD
Zidovudine—ABCC4—Platelet degranulation—VEGFA—psoriasis	7.03e-05	0.00175	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—CAT—psoriasis	7.03e-05	0.00175	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—CRP—psoriasis	7.03e-05	0.00175	CbGpPWpGaD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—CP—psoriasis	7.02e-05	0.00175	CbGpPWpGaD
Zidovudine—Gastrointestinal disorder—Betamethasone—psoriasis	7.01e-05	0.000315	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Dexamethasone—psoriasis	7.01e-05	0.000315	CcSEcCtD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.01e-05	0.00174	CbGpPWpGaD
Zidovudine—Back pain—Methotrexate—psoriasis	7.01e-05	0.000315	CcSEcCtD
Zidovudine—Fatigue—Dexamethasone—psoriasis	7e-05	0.000315	CcSEcCtD
Zidovudine—Fatigue—Betamethasone—psoriasis	7e-05	0.000315	CcSEcCtD
Zidovudine—Shock—Prednisone—psoriasis	6.96e-05	0.000313	CcSEcCtD
Zidovudine—Pain—Betamethasone—psoriasis	6.94e-05	0.000312	CcSEcCtD
Zidovudine—Pain—Dexamethasone—psoriasis	6.94e-05	0.000312	CcSEcCtD
Zidovudine—Nervous system disorder—Prednisone—psoriasis	6.94e-05	0.000312	CcSEcCtD
Zidovudine—Dizziness—Mycophenolate mofetil—psoriasis	6.9e-05	0.00031	CcSEcCtD
Zidovudine—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	6.88e-05	0.00171	CbGpPWpGaD
Zidovudine—Skin disorder—Prednisone—psoriasis	6.87e-05	0.000309	CcSEcCtD
Zidovudine—Hyperhidrosis—Prednisone—psoriasis	6.84e-05	0.000307	CcSEcCtD
Zidovudine—Asthenia—Hydrocortisone—psoriasis	6.82e-05	0.000306	CcSEcCtD
Zidovudine—Vomiting—Cyclosporine—psoriasis	6.8e-05	0.000306	CcSEcCtD
Zidovudine—ABCC4—Hemostasis—ITGAL—psoriasis	6.76e-05	0.00168	CbGpPWpGaD
Zidovudine—Rash—Cyclosporine—psoriasis	6.74e-05	0.000303	CcSEcCtD
Zidovudine—Anorexia—Prednisone—psoriasis	6.74e-05	0.000303	CcSEcCtD
Zidovudine—Dermatitis—Cyclosporine—psoriasis	6.74e-05	0.000303	CcSEcCtD
Zidovudine—Pruritus—Hydrocortisone—psoriasis	6.73e-05	0.000302	CcSEcCtD
Zidovudine—Ill-defined disorder—Methotrexate—psoriasis	6.72e-05	0.000302	CcSEcCtD
Zidovudine—Headache—Cyclosporine—psoriasis	6.7e-05	0.000301	CcSEcCtD
Zidovudine—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	6.7e-05	0.00167	CbGpPWpGaD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—CARM1—psoriasis	6.7e-05	0.00166	CbGpPWpGaD
Zidovudine—Anaemia—Methotrexate—psoriasis	6.69e-05	0.000301	CcSEcCtD
Zidovudine—Feeling abnormal—Dexamethasone—psoriasis	6.69e-05	0.000301	CcSEcCtD
Zidovudine—Feeling abnormal—Betamethasone—psoriasis	6.69e-05	0.000301	CcSEcCtD
Zidovudine—Gastrointestinal pain—Dexamethasone—psoriasis	6.64e-05	0.000298	CcSEcCtD
Zidovudine—Gastrointestinal pain—Betamethasone—psoriasis	6.64e-05	0.000298	CcSEcCtD
Zidovudine—Vomiting—Mycophenolate mofetil—psoriasis	6.63e-05	0.000298	CcSEcCtD
Zidovudine—Rash—Mycophenolate mofetil—psoriasis	6.58e-05	0.000296	CcSEcCtD
Zidovudine—Dermatitis—Mycophenolate mofetil—psoriasis	6.57e-05	0.000295	CcSEcCtD
Zidovudine—Headache—Mycophenolate mofetil—psoriasis	6.54e-05	0.000294	CcSEcCtD
Zidovudine—Malaise—Methotrexate—psoriasis	6.53e-05	0.000293	CcSEcCtD
Zidovudine—Vertigo—Methotrexate—psoriasis	6.51e-05	0.000292	CcSEcCtD
Zidovudine—Diarrhoea—Hydrocortisone—psoriasis	6.5e-05	0.000292	CcSEcCtD
Zidovudine—Leukopenia—Methotrexate—psoriasis	6.48e-05	0.000291	CcSEcCtD
Zidovudine—UGT2B7—Metabolism—NDUFA5—psoriasis	6.47e-05	0.00161	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—ICAM1—psoriasis	6.46e-05	0.00161	CbGpPWpGaD
Zidovudine—Urticaria—Dexamethasone—psoriasis	6.45e-05	0.00029	CcSEcCtD
Zidovudine—Urticaria—Betamethasone—psoriasis	6.45e-05	0.00029	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Prednisone—psoriasis	6.44e-05	0.000289	CcSEcCtD
Zidovudine—Dizziness—Prednisolone—psoriasis	6.44e-05	0.000289	CcSEcCtD
Zidovudine—Asthenia—Triamcinolone—psoriasis	6.42e-05	0.000289	CcSEcCtD
Zidovudine—Abdominal pain—Dexamethasone—psoriasis	6.42e-05	0.000288	CcSEcCtD
Zidovudine—Body temperature increased—Dexamethasone—psoriasis	6.42e-05	0.000288	CcSEcCtD
Zidovudine—Abdominal pain—Betamethasone—psoriasis	6.42e-05	0.000288	CcSEcCtD
Zidovudine—Body temperature increased—Betamethasone—psoriasis	6.42e-05	0.000288	CcSEcCtD
Zidovudine—Insomnia—Prednisone—psoriasis	6.4e-05	0.000287	CcSEcCtD
Zidovudine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	6.38e-05	0.00159	CbGpPWpGaD
Zidovudine—Nausea—Cyclosporine—psoriasis	6.35e-05	0.000285	CcSEcCtD
Zidovudine—Paraesthesia—Prednisone—psoriasis	6.35e-05	0.000285	CcSEcCtD
Zidovudine—ABCB1—Allograft Rejection—IL10—psoriasis	6.34e-05	0.00158	CbGpPWpGaD
Zidovudine—Pruritus—Triamcinolone—psoriasis	6.33e-05	0.000284	CcSEcCtD
Zidovudine—Cough—Methotrexate—psoriasis	6.32e-05	0.000284	CcSEcCtD
Zidovudine—Dizziness—Hydrocortisone—psoriasis	6.29e-05	0.000282	CcSEcCtD
Zidovudine—Convulsion—Methotrexate—psoriasis	6.27e-05	0.000282	CcSEcCtD
Zidovudine—Dyspepsia—Prednisone—psoriasis	6.23e-05	0.00028	CcSEcCtD
Zidovudine—Nausea—Mycophenolate mofetil—psoriasis	6.2e-05	0.000278	CcSEcCtD
Zidovudine—ABCB1—Allograft Rejection—IL4—psoriasis	6.17e-05	0.00153	CbGpPWpGaD
Zidovudine—Arthralgia—Methotrexate—psoriasis	6.17e-05	0.000277	CcSEcCtD
Zidovudine—Chest pain—Methotrexate—psoriasis	6.17e-05	0.000277	CcSEcCtD
Zidovudine—Myalgia—Methotrexate—psoriasis	6.17e-05	0.000277	CcSEcCtD
Zidovudine—Decreased appetite—Prednisone—psoriasis	6.15e-05	0.000276	CcSEcCtD
Zidovudine—Rash—Prednisolone—psoriasis	6.14e-05	0.000276	CcSEcCtD
Zidovudine—Dermatitis—Prednisolone—psoriasis	6.13e-05	0.000275	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	6.12e-05	0.000275	CcSEcCtD
Zidovudine—Fatigue—Prednisone—psoriasis	6.1e-05	0.000274	CcSEcCtD
Zidovudine—Headache—Prednisolone—psoriasis	6.1e-05	0.000274	CcSEcCtD
Zidovudine—Discomfort—Methotrexate—psoriasis	6.09e-05	0.000274	CcSEcCtD
Zidovudine—Constipation—Prednisone—psoriasis	6.05e-05	0.000272	CcSEcCtD
Zidovudine—Vomiting—Hydrocortisone—psoriasis	6.04e-05	0.000272	CcSEcCtD
Zidovudine—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	6.04e-05	0.0015	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.03e-05	0.0015	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.02e-05	0.0015	CbGpPWpGaD
Zidovudine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	6.01e-05	0.0015	CbGpPWpGaD
Zidovudine—Rash—Hydrocortisone—psoriasis	5.99e-05	0.000269	CcSEcCtD
Zidovudine—Dermatitis—Hydrocortisone—psoriasis	5.99e-05	0.000269	CcSEcCtD
Zidovudine—Confusional state—Methotrexate—psoriasis	5.96e-05	0.000268	CcSEcCtD
Zidovudine—Headache—Hydrocortisone—psoriasis	5.95e-05	0.000268	CcSEcCtD
Zidovudine—Dizziness—Triamcinolone—psoriasis	5.92e-05	0.000266	CcSEcCtD
Zidovudine—Anaphylactic shock—Methotrexate—psoriasis	5.91e-05	0.000266	CcSEcCtD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—CP—psoriasis	5.9e-05	0.00147	CbGpPWpGaD
Zidovudine—Feeling abnormal—Prednisone—psoriasis	5.83e-05	0.000262	CcSEcCtD
Zidovudine—Asthenia—Dexamethasone—psoriasis	5.83e-05	0.000262	CcSEcCtD
Zidovudine—Asthenia—Betamethasone—psoriasis	5.83e-05	0.000262	CcSEcCtD
Zidovudine—Nervous system disorder—Methotrexate—psoriasis	5.8e-05	0.00026	CcSEcCtD
Zidovudine—Thrombocytopenia—Methotrexate—psoriasis	5.79e-05	0.00026	CcSEcCtD
Zidovudine—Gastrointestinal pain—Prednisone—psoriasis	5.78e-05	0.00026	CcSEcCtD
Zidovudine—Nausea—Prednisolone—psoriasis	5.78e-05	0.00026	CcSEcCtD
Zidovudine—Pruritus—Betamethasone—psoriasis	5.75e-05	0.000258	CcSEcCtD
Zidovudine—Pruritus—Dexamethasone—psoriasis	5.75e-05	0.000258	CcSEcCtD
Zidovudine—Skin disorder—Methotrexate—psoriasis	5.74e-05	0.000258	CcSEcCtD
Zidovudine—Hyperhidrosis—Methotrexate—psoriasis	5.71e-05	0.000257	CcSEcCtD
Zidovudine—Vomiting—Triamcinolone—psoriasis	5.69e-05	0.000256	CcSEcCtD
Zidovudine—ABCC4—Transmembrane transport of small molecules—CP—psoriasis	5.66e-05	0.00141	CbGpPWpGaD
Zidovudine—Nausea—Hydrocortisone—psoriasis	5.65e-05	0.000254	CcSEcCtD
Zidovudine—Rash—Triamcinolone—psoriasis	5.64e-05	0.000254	CcSEcCtD
Zidovudine—Dermatitis—Triamcinolone—psoriasis	5.64e-05	0.000253	CcSEcCtD
Zidovudine—Anorexia—Methotrexate—psoriasis	5.63e-05	0.000253	CcSEcCtD
Zidovudine—TK1—Metabolism—CAT—psoriasis	5.63e-05	0.0014	CbGpPWpGaD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—CARM1—psoriasis	5.63e-05	0.0014	CbGpPWpGaD
Zidovudine—Urticaria—Prednisone—psoriasis	5.62e-05	0.000252	CcSEcCtD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.61e-05	0.0014	CbGpPWpGaD
Zidovudine—Headache—Triamcinolone—psoriasis	5.61e-05	0.000252	CcSEcCtD
Zidovudine—Abdominal pain—Prednisone—psoriasis	5.59e-05	0.000251	CcSEcCtD
Zidovudine—Body temperature increased—Prednisone—psoriasis	5.59e-05	0.000251	CcSEcCtD
Zidovudine—ABCB1—Allograft Rejection—HLA-A—psoriasis	5.59e-05	0.00139	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—CRP—psoriasis	5.58e-05	0.00139	CbGpPWpGaD
Zidovudine—Diarrhoea—Dexamethasone—psoriasis	5.56e-05	0.00025	CcSEcCtD
Zidovudine—Diarrhoea—Betamethasone—psoriasis	5.56e-05	0.00025	CcSEcCtD
Zidovudine—UGT2B7—Metabolism—CYP2S1—psoriasis	5.5e-05	0.00137	CbGpPWpGaD
Zidovudine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.5e-05	0.00137	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—CARM1—psoriasis	5.4e-05	0.00134	CbGpPWpGaD
Zidovudine—Musculoskeletal discomfort—Methotrexate—psoriasis	5.39e-05	0.000242	CcSEcCtD
Zidovudine—Dizziness—Betamethasone—psoriasis	5.37e-05	0.000241	CcSEcCtD
Zidovudine—Dizziness—Dexamethasone—psoriasis	5.37e-05	0.000241	CcSEcCtD
Zidovudine—Insomnia—Methotrexate—psoriasis	5.35e-05	0.00024	CcSEcCtD
Zidovudine—Nausea—Triamcinolone—psoriasis	5.32e-05	0.000239	CcSEcCtD
Zidovudine—Paraesthesia—Methotrexate—psoriasis	5.31e-05	0.000238	CcSEcCtD
Zidovudine—Dyspnoea—Methotrexate—psoriasis	5.27e-05	0.000237	CcSEcCtD
Zidovudine—Somnolence—Methotrexate—psoriasis	5.25e-05	0.000236	CcSEcCtD
Zidovudine—Dyspepsia—Methotrexate—psoriasis	5.2e-05	0.000234	CcSEcCtD
Zidovudine—Vomiting—Dexamethasone—psoriasis	5.16e-05	0.000232	CcSEcCtD
Zidovudine—Vomiting—Betamethasone—psoriasis	5.16e-05	0.000232	CcSEcCtD
Zidovudine—Decreased appetite—Methotrexate—psoriasis	5.14e-05	0.000231	CcSEcCtD
Zidovudine—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	5.13e-05	0.00128	CbGpPWpGaD
Zidovudine—Rash—Betamethasone—psoriasis	5.12e-05	0.00023	CcSEcCtD
Zidovudine—Rash—Dexamethasone—psoriasis	5.12e-05	0.00023	CcSEcCtD
Zidovudine—Dermatitis—Dexamethasone—psoriasis	5.12e-05	0.00023	CcSEcCtD
Zidovudine—Dermatitis—Betamethasone—psoriasis	5.12e-05	0.00023	CcSEcCtD
Zidovudine—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.11e-05	0.00127	CbGpPWpGaD
Zidovudine—Gastrointestinal disorder—Methotrexate—psoriasis	5.1e-05	0.000229	CcSEcCtD
Zidovudine—Fatigue—Methotrexate—psoriasis	5.1e-05	0.000229	CcSEcCtD
Zidovudine—Headache—Betamethasone—psoriasis	5.09e-05	0.000229	CcSEcCtD
Zidovudine—Headache—Dexamethasone—psoriasis	5.09e-05	0.000229	CcSEcCtD
Zidovudine—Asthenia—Prednisone—psoriasis	5.07e-05	0.000228	CcSEcCtD
Zidovudine—TERT—Disease—HLA-A—psoriasis	5.06e-05	0.00126	CbGpPWpGaD
Zidovudine—Pain—Methotrexate—psoriasis	5.05e-05	0.000227	CcSEcCtD
Zidovudine—ALB—SLC-mediated transmembrane transport—CP—psoriasis	5.04e-05	0.00125	CbGpPWpGaD
Zidovudine—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	5.03e-05	0.00125	CbGpPWpGaD
Zidovudine—Pruritus—Prednisone—psoriasis	5e-05	0.000225	CcSEcCtD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—CP—psoriasis	4.92e-05	0.00122	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—IFNG—psoriasis	4.91e-05	0.00122	CbGpPWpGaD
Zidovudine—Feeling abnormal—Methotrexate—psoriasis	4.87e-05	0.000219	CcSEcCtD
Zidovudine—Diarrhoea—Prednisone—psoriasis	4.84e-05	0.000217	CcSEcCtD
Zidovudine—Gastrointestinal pain—Methotrexate—psoriasis	4.83e-05	0.000217	CcSEcCtD
Zidovudine—Nausea—Betamethasone—psoriasis	4.82e-05	0.000217	CcSEcCtD
Zidovudine—Nausea—Dexamethasone—psoriasis	4.82e-05	0.000217	CcSEcCtD
Zidovudine—TERT—Disease—APOE—psoriasis	4.73e-05	0.00118	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—CARM1—psoriasis	4.7e-05	0.00117	CbGpPWpGaD
Zidovudine—Urticaria—Methotrexate—psoriasis	4.7e-05	0.000211	CcSEcCtD
Zidovudine—Dizziness—Prednisone—psoriasis	4.68e-05	0.00021	CcSEcCtD
Zidovudine—Body temperature increased—Methotrexate—psoriasis	4.67e-05	0.00021	CcSEcCtD
Zidovudine—Abdominal pain—Methotrexate—psoriasis	4.67e-05	0.00021	CcSEcCtD
Zidovudine—Vomiting—Prednisone—psoriasis	4.5e-05	0.000202	CcSEcCtD
Zidovudine—TERT—Signaling Pathways—SOCS1—psoriasis	4.48e-05	0.00112	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—NDUFA5—psoriasis	4.46e-05	0.00111	CbGpPWpGaD
Zidovudine—Rash—Prednisone—psoriasis	4.46e-05	0.0002	CcSEcCtD
Zidovudine—Dermatitis—Prednisone—psoriasis	4.46e-05	0.0002	CcSEcCtD
Zidovudine—Headache—Prednisone—psoriasis	4.43e-05	0.000199	CcSEcCtD
Zidovudine—SLC22A2—Metabolism—NDUFA5—psoriasis	4.42e-05	0.0011	CbGpPWpGaD
Zidovudine—TERT—Disease—NOS2—psoriasis	4.4e-05	0.0011	CbGpPWpGaD
Zidovudine—TK1—Metabolism—APOE—psoriasis	4.38e-05	0.00109	CbGpPWpGaD
Zidovudine—Asthenia—Methotrexate—psoriasis	4.24e-05	0.000191	CcSEcCtD
Zidovudine—Nausea—Prednisone—psoriasis	4.2e-05	0.000189	CcSEcCtD
Zidovudine—Pruritus—Methotrexate—psoriasis	4.18e-05	0.000188	CcSEcCtD
Zidovudine—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	4.15e-05	0.00103	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—CP—psoriasis	4.1e-05	0.00102	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—NFKB1—psoriasis	4.09e-05	0.00102	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—NDUFA5—psoriasis	4.05e-05	0.00101	CbGpPWpGaD
Zidovudine—Diarrhoea—Methotrexate—psoriasis	4.04e-05	0.000182	CcSEcCtD
Zidovudine—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	3.96e-05	0.000984	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—CARM1—psoriasis	3.92e-05	0.000974	CbGpPWpGaD
Zidovudine—ALB—Vitamin B12 Metabolism—TNF—psoriasis	3.91e-05	0.000972	CbGpPWpGaD
Zidovudine—Dizziness—Methotrexate—psoriasis	3.91e-05	0.000176	CcSEcCtD
Zidovudine—ALB—Selenium Micronutrient Network—IFNG—psoriasis	3.9e-05	0.000971	CbGpPWpGaD
Zidovudine—TK1—Metabolism—PPARG—psoriasis	3.81e-05	0.000948	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CYP2S1—psoriasis	3.79e-05	0.000944	CbGpPWpGaD
Zidovudine—Vomiting—Methotrexate—psoriasis	3.76e-05	0.000169	CcSEcCtD
Zidovudine—TERT—Cell Cycle—TP53—psoriasis	3.76e-05	0.000934	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CYP2S1—psoriasis	3.76e-05	0.000934	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—IFNG—psoriasis	3.73e-05	0.000927	CbGpPWpGaD
Zidovudine—Rash—Methotrexate—psoriasis	3.73e-05	0.000167	CcSEcCtD
Zidovudine—Dermatitis—Methotrexate—psoriasis	3.72e-05	0.000167	CcSEcCtD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.72e-05	0.000925	CbGpPWpGaD
Zidovudine—Headache—Methotrexate—psoriasis	3.7e-05	0.000166	CcSEcCtD
Zidovudine—ABCC5—Metabolism—CARM1—psoriasis	3.65e-05	0.000906	CbGpPWpGaD
Zidovudine—TERT—Disease—TYK2—psoriasis	3.61e-05	0.000897	CbGpPWpGaD
Zidovudine—Nausea—Methotrexate—psoriasis	3.51e-05	0.000158	CcSEcCtD
Zidovudine—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.47e-05	0.000862	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CYP2S1—psoriasis	3.45e-05	0.000857	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—LEP—psoriasis	3.31e-05	0.000823	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—APOE—psoriasis	3.31e-05	0.000823	CbGpPWpGaD
Zidovudine—TERT—Disease—CD4—psoriasis	3.26e-05	0.000811	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.25e-05	0.000809	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	3.25e-05	0.000808	CbGpPWpGaD
Zidovudine—ALB—Platelet degranulation—VEGFA—psoriasis	3.18e-05	0.000791	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—TNF—psoriasis	3.18e-05	0.000791	CbGpPWpGaD
Zidovudine—ALB—Vitamin B12 Metabolism—IL6—psoriasis	3.15e-05	0.000784	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—VEGFA—psoriasis	3.12e-05	0.000776	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—NFKBIA—psoriasis	3.08e-05	0.000767	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—ITGAL—psoriasis	3.06e-05	0.000761	CbGpPWpGaD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	3.03e-05	0.000754	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.86e-05	0.00071	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.82e-05	0.0007	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—TP53—psoriasis	2.8e-05	0.000697	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—NOS2—psoriasis	2.78e-05	0.00069	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—NDUFA5—psoriasis	2.77e-05	0.000689	CbGpPWpGaD
Zidovudine—ALB—Metabolism—NDUFA5—psoriasis	2.75e-05	0.000685	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—CARM1—psoriasis	2.69e-05	0.000668	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.58e-05	0.000642	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.57e-05	0.000638	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—IL6—psoriasis	2.57e-05	0.000638	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—CP—psoriasis	2.56e-05	0.000636	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—TNF—psoriasis	2.53e-05	0.000628	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TYK2—psoriasis	2.53e-05	0.000628	CbGpPWpGaD
Zidovudine—TERT—Disease—STAT3—psoriasis	2.53e-05	0.000628	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—NDUFA5—psoriasis	2.47e-05	0.000615	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	2.44e-05	0.000607	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—TNF—psoriasis	2.41e-05	0.0006	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—NDUFA5—psoriasis	2.41e-05	0.0006	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.4e-05	0.000597	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP2S1—psoriasis	2.35e-05	0.000586	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP2S1—psoriasis	2.34e-05	0.000582	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.3e-05	0.000573	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—NDUFA5—psoriasis	2.25e-05	0.00056	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—CAT—psoriasis	2.24e-05	0.000558	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.24e-05	0.000558	CbGpPWpGaD
Zidovudine—ABCC5—Disease—HLA-A—psoriasis	2.23e-05	0.000554	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CXCL8—psoriasis	2.2e-05	0.000547	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.14e-05	0.000532	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP2S1—psoriasis	2.1e-05	0.000523	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.1e-05	0.000523	CbGpPWpGaD
Zidovudine—ABCC5—Disease—APOE—psoriasis	2.08e-05	0.000517	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP2S1—psoriasis	2.05e-05	0.00051	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—JUN—psoriasis	2.04e-05	0.000508	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—IL6—psoriasis	2.04e-05	0.000507	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—NFKB1—psoriasis	1.97e-05	0.000489	CbGpPWpGaD
Zidovudine—ABCC5—Disease—NOS2—psoriasis	1.94e-05	0.000482	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP2S1—psoriasis	1.92e-05	0.000477	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CARM1—psoriasis	1.85e-05	0.000461	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CARM1—psoriasis	1.83e-05	0.000456	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—VEGFA—psoriasis	1.79e-05	0.000444	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—STAT3—psoriasis	1.77e-05	0.00044	CbGpPWpGaD
Zidovudine—TERT—Disease—IL6—psoriasis	1.76e-05	0.000439	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—APOE—psoriasis	1.74e-05	0.000433	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CARM1—psoriasis	1.68e-05	0.000419	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—CAT—psoriasis	1.65e-05	0.000411	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—VEGFA—psoriasis	1.61e-05	0.0004	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.59e-05	0.000396	CbGpPWpGaD
Zidovudine—ABCC5—Disease—TYK2—psoriasis	1.59e-05	0.000395	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.53e-05	0.000381	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PPARG—psoriasis	1.52e-05	0.000377	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NDUFA5—psoriasis	1.49e-05	0.00037	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CD4—psoriasis	1.44e-05	0.000357	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.41e-05	0.000351	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.39e-05	0.000346	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TP53—psoriasis	1.35e-05	0.000336	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—APOE—psoriasis	1.28e-05	0.000319	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.26e-05	0.000314	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—NOS2—psoriasis	1.26e-05	0.000312	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—IL6—psoriasis	1.24e-05	0.000307	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.23e-05	0.000307	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.23e-05	0.000305	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TP53—psoriasis	1.21e-05	0.000302	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.19e-05	0.000296	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CARM1—psoriasis	1.15e-05	0.000286	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CARM1—psoriasis	1.14e-05	0.000284	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CAT—psoriasis	1.14e-05	0.000283	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CAT—psoriasis	1.13e-05	0.00028	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PPARG—psoriasis	1.12e-05	0.000278	CbGpPWpGaD
Zidovudine—ABCC5—Disease—STAT3—psoriasis	1.11e-05	0.000276	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.1e-05	0.000274	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.07e-05	0.000267	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.07e-05	0.000266	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.05e-05	0.000261	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CAT—psoriasis	1.04e-05	0.000257	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CARM1—psoriasis	1.03e-05	0.000255	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1e-05	0.00025	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CARM1—psoriasis	1e-05	0.000249	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.59e-06	0.000239	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CARM1—psoriasis	9.36e-06	0.000233	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—APOE—psoriasis	8.86e-06	0.00022	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—APOE—psoriasis	8.76e-06	0.000218	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.75e-06	0.000218	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—APOE—psoriasis	8.05e-06	0.0002	CbGpPWpGaD
Zidovudine—ABCC5—Disease—IL6—psoriasis	7.77e-06	0.000193	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PPARG—psoriasis	7.71e-06	0.000192	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PPARG—psoriasis	7.63e-06	0.00019	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—VEGFA—psoriasis	7.28e-06	0.000181	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CAT—psoriasis	7.07e-06	0.000176	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CAT—psoriasis	7.03e-06	0.000175	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PPARG—psoriasis	7.01e-06	0.000174	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CAT—psoriasis	6.31e-06	0.000157	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CARM1—psoriasis	6.17e-06	0.000153	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CAT—psoriasis	6.16e-06	0.000153	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CAT—psoriasis	5.76e-06	0.000143	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—psoriasis	5.5e-06	0.000137	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—APOE—psoriasis	5.5e-06	0.000137	CbGpPWpGaD
Zidovudine—ALB—Metabolism—APOE—psoriasis	5.46e-06	0.000136	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—APOE—psoriasis	4.91e-06	0.000122	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—APOE—psoriasis	4.79e-06	0.000119	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PPARG—psoriasis	4.79e-06	0.000119	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PPARG—psoriasis	4.76e-06	0.000118	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—APOE—psoriasis	4.47e-06	0.000111	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PPARG—psoriasis	4.27e-06	0.000106	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PPARG—psoriasis	4.17e-06	0.000104	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PPARG—psoriasis	3.9e-06	9.69e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CAT—psoriasis	3.8e-06	9.44e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—APOE—psoriasis	2.95e-06	7.34e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PPARG—psoriasis	2.57e-06	6.39e-05	CbGpPWpGaD
